oxatomide has been researched along with prostaglandin d2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, Y; Misawa, M | 1 |
| Ishii, A; Kawabe, H; Kosaka, Y | 1 |
| de Crescenzo, G; Genovese, A; Marino, O; Marone, G; Patella, V; Spadaro, G | 1 |
3 other study(ies) available for oxatomide and prostaglandin d2
| Article | Year |
|---|---|
Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Bronchoconstriction; Dibenzazepines; Guinea Pigs; Histamine; Histamine H1 Antagonists; Imidazoles; Ketotifen; Male; Neurokinin A; Phthalazines; Piperazines; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; SRS-A; Substance P | 1991 |
Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Cromolyn Sodium; Guinea Pigs; Ketotifen; Lung; Mast Cells; ortho-Aminobenzoates; Piperazines; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins D; Rats; SRS-A | 1987 |
Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Topics: Adult; Basophils; Cells, Cultured; Chymases; Histamine H1 Antagonists; Histamine Release; Humans; Leukotriene C4; Lung; Mast Cells; Middle Aged; Piperazines; Prostaglandin D2; Serine Endopeptidases; Skin; Tryptases | 1996 |